BIO-TECHNE Corp — Director's Dealing 2018

Aug 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2018-08-08

Reporting Person: Kelderman Kim (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-08	Restricted Stock Units	$	A	1691.00	Acquired		Common Stock (1691.00)	Direct
2018-08-08	Stock Options (Right to buy)	$177.32	A	12044.00	Acquired	2025-08-08	Common Stock (12044.00)	Direct
2018-08-08	Stock Options (Right to buy)	$177.32	A	9033.00	Acquired	2025-08-08	Common Stock (9033.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$	2025-05-01	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to buy)	$150.78	2025-05-01	Common Stock (2652.00)	2652.00	Direct
Stock Options (Right to buy)	$150.78	2025-05-01	Common Stock (7348.00)	7348.00	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F3: Vests 3,011 shares each on 8/8/2019, 8/8/2020, 8/8/2021, 8/8/2022

F4: Vests 1667 shares on 5/1/2019, 1,666 shares each on 5/1/2020 and 1,667 shares on 5/1/2021

F5: 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022

F6: 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022